Advent International

News

Zentiva set to change hands in €4.1bn private equity deal

Ex-Sanofi generics company Zentiva is poised for a sale by current owner Advent International to US investment group GTCR, says a media report.

News

Did AZ scupper Sobi's $8bn private equity buyout?

An $8 billion attempt by two private equity companies to acquire Swedish rare disease specialist Sobi and take it back into private ownership has collapsed, with reports suggesting AstraZen

News

Sanofi in final stages of negotiation in sale of generics ar...

Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International.

Zentiva set to change hands in €4.1bn private equity deal

Did AZ scupper Sobi's $8bn private equity buyout?

Sanofi in final stages of negotiation in sale of generics ar...

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks